Riociguat (adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

Vallerie V. McLaughlin, Stephen L. Archer, David B. Badesch et al. · Journal of the American College of Cardiology · 2009 · 2.3K citations

Hypertension, Pulmonary Arterial Hypertension, Pulmonary Care +6

Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension

Hossein Ardeschir Ghofrani, Andrea Maria D’Armini, Friedrich Grimminger et al. · New England Journal of Medicine · 2013 · 1.4K citations · Full text

Riociguat for the Treatment of Pulmonary Arterial Hypertension

Hossein Ardeschir Ghofrani, Nazzareno Galiè, Friedrich Grimminger et al. · New England Journal of Medicine · 2013 · 1.3K citations · Full text

An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry

Raymond L. Benza, Dave P. Miller, Robyn J. Barst et al. · CHEST Journal · 2012 · 1.1K citations

Prognostic Evaluation, Hypertension, Pulmonary Arterial Hypertension +9

Pulmonary Arterial Hypertension

Michael D. McGoon, Raymond L. Benza, Pilar Escribano Subías et al. · Journal of the American College of Cardiology · 2013 · 506 citations

Hypertension, Pulmonary Arterial Hypertension, Pulmonary Circulation +8